🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the progression-free survival of ...
Status
Completed
Location
University of Oklahoma Health Sciences Center
Start Date
2007-09
Trial ID
NCT00542490
Treatments Being Tested
This randomized phase III trial studies pelvic radiation therapy to see how...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-03-23
Trial ID
NCT00807768
The purpose of this study is to determine the feasibility of treatment in p...
Status
Completed
Location
Stephenson Cancer Center
Start Date
2017-10-02
Trial ID
NCT03189446
Treatments Being Tested
The PURE trial is a prospective multicenter phase II study evaluating the s...
Status
Recruiting
Location
Unidad Clínica Multihospitalaria de Oncología Radioterápica de Aragón (UCMORA)
Start Date
2026-03-30
Trial ID
NCT07779109
The purpose of this study is to investigate the effect of certain variables...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2004-01
Trial ID
NCT00165126
Treatments Being Tested
This randomized phase III trial studies short course vaginal cuff brachythe...
Status
Recruiting
Location
Stanford Cancer Center
Start Date
2018-02-02
Trial ID
NCT03422198
Treatments Being Tested
The purpose of this single arm, open label study is to evaluate the feasibi...
Status
Active Not Recruiting
Location
LSU Health New Orleans
Start Date
2020-02-19
Trial ID
NCT03932409
Treatments Being Tested
The purpose of this study is to see the effects of two different standard o...
Status
Recruiting
Location
University of Maryland Medical Center (UMMC)
Start Date
2019-01-17
Trial ID
NCT03785288
Treatments Being Tested
This phase III trial tests whether adding trastuzumab and hyaluronidase-oys...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-16
Trial ID
NCT05256225